ライフサイエンスコーパス: population at risk

1 de a more precisely targeted therapy for the population at risk.

2 ach may neglect a significant portion of the population at risk.

3 ing cancer, need to be determined in a large population at risk.

4 blic health threat, with half of the world's population at risk.

5 and nonmalignant disorders has enlarged the population at risk.

6 UNV is currently used to vaccinate the human population at risk.

7 igher estimated impact than AL in 64% of the population at risk.

8 studies, however, were not adjusted for the population at risk.

9 vey, and administrative data to estimate the population at risk.

10 y denominator file was used to determine the population at risk.

11 as generated and used to vaccinate the human population at risk.

12 identify >/=5-cm diameter AAAs in the entire population at risk.

13 e the morbidity and mortality of the patient population at risk.

14 e diagnosed during screening of asymptomatic populations at risk.

15 ssays would allow efficient testing of broad populations at risk.

16 Interaction terms were used to identify populations at risk.

17 centralise care, and to scale up coverage in populations at risk.

18 nal development, significantly underestimate populations at risk.

19 s each year if successfully delivered to the populations at risk.

20 ulcers will allow for better delineation of populations at risk.

21 disparities in glaucoma and better targeting populations at risk.

22 differences might increase attention toward populations at risk.

23 ations, after adjustment for the ages of the populations at risk.

24 ted with increased rates of psychoses in the populations at risk.

25 women, 95% CI 0.13-0.52 vs 0.076 per 100 000 population at risk, 95% CI 0.07-0.09).

26 onal levels: climate suitability, additional population at risk and additional person-months at risk

27 seasonal malaria incidence, and estimate the population at risk and malaria burden in areas where sea

28 tilator-associated event is very common in a population at risk and more importantly highly related t

29 aintenance of high levels of immunity in the population at risk and the establishment of a surveillan

30 cessity, security may be threatened, and the population at risk and their afflictions can be highly d

31 se approaches offer new avenues for treating populations at risk and are of particular significance t

32 Identification of populations at risk and description of structural determ

33 These assays aid in determining potential populations at risk and potential mitigation strategies.

34 The increasingly diverse populations at risk and the recent discovery of the pres

35 mpromise the quality of care provided to the population at risk, and has potential to influence the p

36 esearch, develop predictive tests for PML in populations at risk, and challenge us to find a treatmen

37 identify additional toxicants of concern and populations at risk, and examine potential for similar l

38 on due to the expansion of immunocompromised populations at risk, and therefore are important to reco

39 crucial need for improved access to data on population at risk, animal movements and vaccine use is

40 The difference between the population at risk at elevated and ambient CO2 concentra

41 ealed several emerging issues, including new populations at risk because of travel or relocation, occ

42 limate suitability and a net increase in the population at risk, but with large uncertainties.

43 same spatial resolution were used to compute populations at risk by endemicity class and estimate pop

44 This expanding understanding of the population at risk challenges physicians to carefully ex

45 ibility that 10 or more percent of the world population at risk could eventually be infected with the

46 With an estimated 40% of the world population at risk, dengue poses a significant threat to

47 in environmental media at each site, and the population at risk estimated.

48 until larger, prospective studies define the population at risk for acute phosphate nephropathy, the

49 art, among FCH families and the more general population at risk for CAD.

50 iently identify individuals from the general population at risk for conversion to a clinical diagnosi

51 arly and subtle vascular impairments in this population at risk for CVD such as stroke or WMHs.

52 tions about the course of disease place this population at risk for delayed or inadequate care.

53 in human occasional stimulant users (OSU), a population at risk for dependence.

54 al transplant patients, an immunocompromised population at risk for development of Kaposi's sarcoma.

55 infections may put an immunologically naive population at risk for disease outbreaks.

56 In view of changing perspectives on the population at risk for endocarditis and new information

57 pediatric awareness of the changing patient population at risk for endocarditis and the need for inc

58 oma) and its greater frequency in Koreans (a population at risk for gastric cancer) suggest that this

59 The population at risk for HBV reactivation includes those w

60 ransmitted infections represent a vulnerable population at risk for HIV.

61 g antibiotic resistance and a rising patient population at risk for infection due to impaired immunit

62 nine gender identity, represent a vulnerable population at risk for negative mental health and substa

63 Large segments of the population at risk for osteoporosis and fracture have no

64 HF staging underscores the magnitude of the population at risk for progression to overt HF.

65 of advanced age represent a rapidly growing population at risk for prostate cancer.

66 with outcome in an intensive care unit (ICU) population at risk for sepsis.

67 A substantial proportion of the population at risk for visual loss from age-related macu

68 A field evaluation in a population at risk for vitamin A deficiency (VAD) result

69 This finding increases the population at risk for XMRV infection from only those ho

70 Postoperative pain trajectories identify populations at risk for 30-day readmissions and ED visit

71 men may represent one of the fastest-growing populations at risk for acquiring cervical cancer and th

72 Populations at risk for AD show altered brain activity i

73 ave been carried out in healthy individuals, populations at risk for certain diseases, and patients u

74 the utility of this assay to monitor patient populations at risk for CMV disease is warranted.

75 In other populations at risk for cognitive decline, additional ma

76 ing or retarding liver cancer development in populations at risk for HCC mortality.

77 and useful vaccine against tuberculosis for populations at risk for HIV.

78 We also estimated the sizes of 4 key populations at risk for human immunodeficiency virus inf

79 There is a need to better predict patient populations at risk for immunologically mediated type B

80 tainty associated with future projections of populations at risk for malaria owing to climate change.

81 n of the gut microbiota's viral component in populations at risk for malnutrition.

82 levels below this threshold are common among populations at risk for PH, the relevance of mPAP <25 mm

83 apacity to cultivate healthier microbiota in populations at risk for poor nutrition.

84 Populations at risk for poorer social functioning were l

85 ophrenic patients as well as in a variety of populations at risk for schizophrenia, few studies have

86 lence has mainly been selectively studied in populations at risk for sleep-disordered breathing or ca

87 optimal pre-ESRD care, and identification of populations at risk for suboptimal pre-ESRD care.

88 ence, enabling the correct identification of populations at risk for transmission within the United S

89 nostic capacity, including blood culture, to populations at risk for typhoid fever in Africa will imp

90 apid screening of carotenoid levels in large populations at risk for vision loss from age-related mac

91 opes can be applied to the identification of populations at risk for zinc deficiency and to monitorin

92 ty, is beneficial for broad screening of the population at risk from elevated arsenic in drinking wat

93 Three of the eight studies overestimate populations at risk from actively producing oil and gas

94 ptive gene flow as a conservation option for populations at risk from climate change.

95 d the increasing accuracy in delineating the population at risk, have laid the foundation for future

96 In a population at risk, higher DOPBP during continuous flow

97 per year in 43.4% (95% CI 40.0-49.0) of the population at risk in Africa.

98 men bear the largest burden of HIV among any population at risk in Brazil.

99 ompared with data on parasite prevalence and populations at risk in sub-Saharan Africa.

100 We discuss competing risks and populations at risk in the context of appropriate numera

101 jections constitute a revised upper limit of populations at risk in the current Zika epidemic, and ou

102 the extent of measles virus circulation and populations at risk in the United States, we reviewed me

103 sudden death rates remain undaunted and the population at risk is rapidly increasing.

104 " (i.e., new infrastructure or equipment) to populations at risk, it might be necessary to also provi

105 e of humans, with almost half of the world's population at risk of infection.

106 tick-related knowledge and behaviors among a population at risk of Lyme disease.

107 ct the outcome of genetic testing in a large population at risk of Lynch syndrome.

108 rapolation of the prevalence estimate to the population at risk of malaria in DRC suggests 1.015 mill

109 ia vaccines for the one-third of the world's population at risk of malaria infection.

110 edle-free vaccine for the 40% of the world's population at risk of malaria.

111 The mean percentage of the CD European population at risk of mucosal damage resulting from cons

112 of this study was to determine the adult CHD population at risk of SCD and the clinical parameters as

113 long life, increasing the size of the ageing population at risk of stroke.

114 will be a significant increase in the human population at risk of zinc deficiency.

115 strategy for increasing vitamin A status in populations at risk of deficiency.

116 erapeutic implications of subclinical ILD in populations at risk of developing clinically significant

117 um drug administration schedules for patient populations at risk of evolving acquired resistance.

118 typing FA assay amenable for screening broad populations at risk of FA.

119 If members of populations at risk of HIV infection who are popular wit

120 tage 1, index-case potential, which assesses populations at risk of infection due to spillover from z

121 stigating their epidemiology and identifying populations at risk of infection.

122 nt will emphasize definitive field trials in populations at risk of malaria to define and improve vac

123 e increasing in prevalence globally, also in populations at risk of malaria.

124 rus-affected areas of the Americas and large populations at risk of mosquito-borne Zika virus infecti

125 ith HER2-positive IBC to identify vulnerable populations at risk of treatment failure.

126 has a positive effect on vitamin A stores in populations at risk of vitamin A deficiency.

127 ren's zinc nutriture should be considered in populations at risk of zinc deficiency, especially where

128 e death, whereas wall thickness identified a population at risk only 18 to 24 months before death.

129 d at increasing EMS activation should target populations at risk, particularly younger patients and t

130 ions in estimates of proportions of national populations at risk range from <0.1% to 45% differences

131 Similar surveys in populations at risk should be performed at regular inter

132 auses, reflect recent secular changes in the population at risk, specific risk factors, and strategie

133 lementation improves outcomes across a broad population at risk, such as in this instance.

134 ver, after adjustment for differences in the populations at risk, the median ages at diagnosis in the

135 s located in this endemic area, and that the population at risk to develop FS may also be at risk to

136 -burden countries and across all genders and populations at risk toward global human immunodeficiency

137 The population at risk was comprised of all adult cardiac re

138 himaera isolates since 2006, and the patient population at risk was prospectively surveyed.

139 accidents or homicide at the workplace, and populations at risk were estimated from the 1980 and 199

140 Patient populations at risk were most commonly critically ill pa

141 e shock syndrome, placing 40% of the world's population at risk with no effective treatment.

142 o compute incidence rates, we estimate older populations at risk with census counts and NIH life tabl